Wednesday, August 5, 2026

HLB Therapeutics CEO: New Eye Drop Could Disrupt the Market for Rare Corneal Disease

HLB Therapeutics CEO anticipates RGN-259 could surpass Oxervate within 3 years as a simpler, cost-effective NK treatment.

NewJeans Danielle Thanks Her ‘Warrior’ CEO in Touching Letter

Min recently shared a heartfelt handwritten letter from NewJeans member Danielle on her Instagram account yesterday.

North Korean Hackers Impersonates U.S. Officials in Sneaky Cyber Attack in South Korea

North Korea's Kimsuky group attempted a cyber attack in South Korea using deceptive ClickFix tactics to impersonate U.S. officials.

Health

5 Key Research Findings on Dr. Noon CVD: A Game-Changer for Cardiovascular Disease Prevention

Mediwhale presented five abstracts on its AI-based cardiovascular risk assessment solution, Dr. Noon CVD, at the ASPC conference.

“Improved Survival Rates”… Carboplatin Combination Therapy Shows Benefit in Triple-Negative Breast Cancer

Adding carboplatin to chemotherapy for operable triple-negative breast cancer reduces recurrence risk and improves survival, study finds.

Inventage Lab Selected for Global TIPS Program, Accelerating Late-Stage Development of Addiction Treatment

Inventis Lab's long-acting drug IVL3004 for addiction treatment has been selected for the Global TIPS research project by the Ministry of SMEs.

Bukwang Pharm Signs Export Agreement With Thailand’s Pacific Healthcare for Dexid

Bukwang Pharmaceutical signs exclusive export contract for diabetes treatment 'Dexide' with Pacific Healthcare in Thailand.

Huawei Unveils OpenPangu 2.0 Pro: Is This the Future of AI with 505 Billion Parameters?

Huawei accelerates its AI ecosystem expansion by revealing the source of its massive AI model with over 500 billion parameters.
Latest

How thynC™ is Revolutionizing Patient Monitoring: Insights from Seers Technology’s Success

Seers Technology aims for global expansion, projecting overseas sales to match domestic by 2029, driven by its innovative AI healthcare solutions.

Samsung Biologics Partners with CEPI: A Game-Changer for Global Vaccine Production

Samsung Biologics partners with CEPI to enhance vaccine production for pandemics, aiming for rapid global supply and health security.

World Cancer Day 2026: How Patient-Centered Care is Transforming Cancer Treatment in Asia

The National Cancer Center joins a global campaign for World Cancer Day, promoting People-Centered Care through dialogue with patients.

How Celltrion’s Omlyclo is Dominating Spain’s Omalizumab Market: A First-Mover Success Story

Celltrion's Omlyclo treatment is thriving in Spain, capturing over 60% of the omalizumab market with innovative strategies and strong demand.

Revolutionizing Antibiotic Use: Insights from Korea’s ASP Model Featured in JAMA

Korea's Antimicrobial Stewardship Program gains international recognition for optimizing antibiotic use and addressing resistance issues.

Anthrax, Plague, and BSL-3 Research: South Korea Checks 47 Safety Items, CCTV, and Records

The KDCA confirmed 100% compliance with biosafety standards in inspections of high-risk pathogen facilities and BSL-3 labs.

GC Biopharma Corp Soars After Eight Years on the Back of Immunodeficiency Drug Alyglo, Posting Results in U.S. Market Push

GC Biopharma Corp breaks its fourth-quarter deficit with ALYGLO's success, achieving $106M in annual revenue and plans for future growth.

GCC2005: The Breakthrough CAR-NK Therapy for T-Cell Lymphoma Unveiled at TCLF 2026

GC Cell presents promising CD5-targeting CAR-NK therapy GCC2005 for T-cell lymphoma, showing significant efficacy and safety at TCLF.

HM15275 Clinical Trials: What You Need to Know About This Groundbreaking Obesity Treatment

Hanmi Pharmaceutical's HM15275 enters Phase 2 trial, aiming to revolutionize obesity treatment and diabetes management by 2030.

Are Your Favorite Sweets Safe? Arsenic Levels in 28 Candy Products Raise Concerns

A Florida study found arsenic in popular candies, alarming consumers, but food safety officials deem levels safe. Industry disputes findings.

How SK Chemical’s Nose-R Soft Cap Stand Out in Allergy Treatment: A Deep Dive into the OTC Market

SK Chemicals partners with Kyung Nam Pharm to enhance Nose-R Soft Cap sales in pharmacies, boosting allergy treatment distribution.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Pneumonia Death Rates in South Korea: Why Vaccination is Crucial for High-Risk Groups

Pneumonia is South Korea's third leading cause of death; prevention is crucial, especially for high-risk groups after influenza.

Unlocking Rare Diseases: How AI and Whole Genome Sequencing Achieved 46.2% Diagnostic Success in Korea

Three Billion, an AI-based rare disease diagnostic company, collaborates with Seoul National University Hospital on a major genomic study.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.